Specificity of the antibody receptor site to D-lysergamide: model of a physiological receptor for lysergic acid diethylamide.
Antibodies to D-lysergic acid have been produced in rabbits and guinea pigs and a radioimmunoassay for the hapten was developed. The specificity of this lysergamide-antilysergamide reaction was determined by competitive binding with unlabeled lysergic acid diethylamide (LSD), psychotomimetic drugs, neurotransmitters, and other compounds with diverse structures. LSD and several related ergot alkaloids were potent competitors, three to seven times more potent than lysergic acid itself. The N,N-dimethyl derivatives of several compounds, including tryptamine, 5-hydroxytryptamine, 4-hydroxytryptamine, 5-methoxytryptamine, tyramine, and mescaline, were only about ten times less effective than lysergic acid, even though these compounds lack some of the ring systems of lysergic acid. The pattern of inhibition by related compounds with various substituents suggests that the antibody receptor site recognizes structural features resembling the LSD molecule. In particular, the aromatic nucleus and the dimethylated ethylamine side chain in phenylethylamine and tryptamine derivatives may assume in solution a conformation resembling ring A and the methylated nitrogen in ring C of LSD. Among the tryptamine derivatives, a large percentage of the most potent competitors are also psychotomimetic compounds.
D000588:Amines; D000818:Animals; D000937:Antigen-Antibody Reactions / Q000187:drug effects; D001665:Binding Sites; D003429:Cross Reactions; D004873:Ergolines; D004874:Ergonovine; D004876:Ergot Alkaloids; D004878:Ergotamine; D006168:Guinea Pigs; D006241:Haptens; D006433:Hemocyanins; D007106:Immune Sera; D007456:Iodine Isotopes; D008238:Lysergic Acid Diethylamide; D008239:Lysine; D008550:Melatonin; D008635:Mescaline; D010627:Phenethylamines; D011108:Polymers; D011562:Psilocybin; D011817:Rabbits; D011863:Radioimmunoassay; D011955:Receptors, Drug; D012701:Serotonin; D013565:Sympatholytics; D013566:Sympathomimetics; D014363:Tryptamines / Q000494:pharmacology; D014439:Tyramine
D000588:Amines; D004873:Ergolines; D004876:Ergot Alkaloids; D006241:Haptens; D007106:Immune Sera; D007456:Iodine Isotopes; D010627:Phenethylamines; D011108:Polymers; D011955:Receptors, Drug; D013565:Sympatholytics; D013566:Sympathomimetics; D014363:Tryptamines; D011562:Psilocybin; D012701:Serotonin; D008238:Lysergic Acid Diethylamide; D006433:Hemocyanins; D008550:Melatonin; D008239:Lysine; D004878:Ergotamine; D008635:Mescaline; D004874:Ergonovine; D014439:Tyramine